Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bojan Ljepoja"'
Autor:
Bojan Ljepoja, Jonathan García-Roman, Ann-Katrin Sommer, Thomas Fröhlich, Georg J. Arnold, Ernst Wagner, Andreas Roidl
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-15 (2018)
Abstract Loss of miR-200c is correlated to advanced cancer-subtypes due to increased EMT and decreased treatment efficacy by chemotherapeutics. As miRNAs regulate a multitude of targets, the analysis of differentially expressed proteins upon a genomi
Externí odkaz:
https://doaj.org/article/33c8ee14553a400c8741f1a8882b0995
Autor:
Bojan Ljepoja, Christoph Schreiber, Florian A Gegenfurtner, Jonathan García-Roman, Bianca Köhler, Stefan Zahler, Joachim O Rädler, Ernst Wagner, Andreas Roidl
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224314 (2019)
Cancer progression and metastases are frequently related to changes of cell motility. Amongst others, the microRNA-200c (miR-200c) was shown to maintain the epithelial state of cells and to hamper migration. Here, we describe two miR-200c inducible b
Externí odkaz:
https://doaj.org/article/1fd649239240459e99eae4b55d1facc4
Autor:
Bianca Köhler, Sviatlana Dubovik, Elisa Hörterer, Ulrich Wilk, Jan Bernd Stöckl, Hande Tekarslan-Sahin, Bojan Ljepoja, Philipp Paulitschke, Thomas Fröhlich, Ernst Wagner, Andreas Roidl
Publikováno v:
Cancers; Volume 14; Issue 22; Pages: 5554
Acquired drug resistance constitutes a serious obstacle to the successful therapy of cancer. In the process of therapy resistance, microRNAs can play important roles. In order to combat resistance formation and to improve the efficacy of chemotherape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a9e36c0d5baad7527a33f1c12847faf
Autor:
Adam Hermawan, Georg J. Arnold, Ann-Katrin Sommer, Ernst Wagner, Andreas Roidl, Bojan Ljepoja, Thomas Fröhlich
Publikováno v:
International Journal of Molecular Medicine
Breast cancer exhibits the highest incidence of all cancer types and is the 2nd leading cause of cancer mortality in women. Up to 82% of breast cancer patients receive a chemotherapy-containing treatment regimen. However, numerous breast tumors recur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a1b13d2a80af4019602784e5af2a48b
http://europepmc.org/articles/PMC6108857
http://europepmc.org/articles/PMC6108857
Autor:
Axel Ullrich, Andreas Roidl, Bojan Ljepoja, Adam Hermawan, Ann-Katrin Sommer, Frauke Martina Mickler, Christoph Bräuchle, Pjotr Knyazev, Ernst Wagner
Publikováno v:
Oncotarget
// Ann-Katrin Sommer 1, 2 , Adam Hermawan 1 , Frauke Martina Mickler 3 , Bojan Ljepoja 1 , Pjotr Knyazev 2 , Christoph Brauchle 3 , Axel Ullrich 2 , Ernst Wagner 1 , Andreas Roidl 1 1 Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maxim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c56c95adb4d97a3719f18af8d80d05
https://doi.org/10.18632/oncotarget.10459
https://doi.org/10.18632/oncotarget.10459
Autor:
Joachim O. Rädler, Andreas Roidl, Florian A. Gegenfurtner, Christoph Schreiber, Bianca Köhler, Bojan Ljepoja, Stefan Zahler, Jonathan García-Roman, Ernst Wagner
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 11, p e0224314 (2019)
PLoS ONE, Vol 14, Iss 11, p e0224314 (2019)
Cancer progression and metastases are frequently related to changes of cell motility. Amongst others, the microRNA-200c (miR-200c) was shown to maintain the epithelial state of cells and to hamper migration. Here, we describe two miR-200c inducible b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88f60d4cdcbe4914ef7b322dd8fd8921
https://doi.org/10.1371/journal.pone.0224314
https://doi.org/10.1371/journal.pone.0224314